The main objective of the study was to find genetic variants that in combination are significantly associated with bipolar disorder. In previous studies of bipolar disorder, combinations of three and Read MoreDownload Attachment
Life Sciences BioinformaticsCambridge, MA
We’re a precision medicine company with patented A.I. deep semantic technology for search and discovery. Our novel high-dimensional analytics find patterns of features in combination associated with disease risk, disease protective effect or predicted therapy response across all forms of data (genomic, phenotypic, lifestyle, clinical, imaging, epigenetic, etc.) on massive data sets scaling from populations to personalized plans. Designed for patient stratification, biomarker discovery, clinical decision support and more. We specialize in “multi-omics hyper-combinatorial” analyses, and our precisionlife platform can analyze 17 or more disease factors in combination. No supercomputer required – only a few GPUs.